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ABSTRACT	
Gabriel	Senties-Ramirez:	Dental	Ankylosis:	Clinical	and	Molecular	Characterization	
(Under	the	direction	of	Sylvia	A.	Frazier-Bowers.)	
	
	
Introduction:	Dental	ankylosis	is	a	histological	definition	for	a	condition	that	is	often	
clinically	 indistinguishable	 from	other	eruption	disorders. 	 Confusion	between	ankylosis	
and	PFE	can	result	 in	an	 inaccurate	diagnosis,	and	inappropriate	orthodontic	
management.	 In	 this	study,	we	tested	the	central	hypothesis	that	ankylosis	is	a	distinct	
pathology	compared	to	PFE	due	to	PTH1R	mutations.	Methods:	1)	We	completed	
mutational	analysis	of	PTH1R	on	patients	with	PFE	(based	on	familial	segregation)	or	
suspected	ankylosis.	 	2)	We	performed	expression	studies	to	compare	PFE	and	ankylosis	 in	
PDL	tissue	of	control	and	affected	extracted	teeth.	Collected	PDL	tissue	from	extracted	
teeth	was	used	to	create	primary	cell	cultures	for	genetic	expression	studies.	Differences	in	
genetic	expression	of	PTH1R,	RANKL,	BMP-2,	BMP-4,	and	BMP-6	at	the	PDL	between	
ankylosed,	control,	and	PFE	teeth	were	tested.	Results:	Differences	in	the	expression	of	
BMP-4,	BMP-6,	and	PTH1R	were	found	between	control,	PFE,	and	ankylosed	teeth.		
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A	REVIEW	OF	THE	LITERATURE	
Tooth	Eruption,	and	its	disorders	
	
Tooth	eruption	is	the	developmental	process	behind	the	movement	of	a	dental	unit	
from	the	crypt	where	it	forms,	across	the	bone	of	the	jaws,	and	into	the	oral	cavity,	towards	its	
place	across	a	functional	occluding	counterpart	31.	Some	clinicians	use	the	term	eruption	to	
refer	to	the	appearance	of	a	tooth	in	the	oral	cavity,	but	a	more	accurate	term	for	this	
milestone	is	emergence	or	moment	of	eruption.	Authors	in	the	literature	advocate	against	using	
the	terms	“eruption”	and	“emergence”	interchangeably	in	order	to	preserve	their	more	specific	
and	separate	meanings31.	Tooth	eruption	in	the	true	sense	of	the	word	is	without	a	doubt	a	
complex	process,	involving	many	tissues	and	cell	types	that	are	coordinated	with	precision	and	
specificity	in	time	and	space31.	The	downside	of	this	very	complexity,	however,	is	that	it	
presents	many	elements	and	mechanisms	that	have	the	potential	to	go	awry.	A	functional	
occlusion	may	not	be	maintained	without	proper	eruption	of	the	teeth,	which	is	why	this	
process	is	an	area	of	study	of	upmost	importance,	not	only	to	orthodontics,	but	to	all	of	
dentistry.	Based	on	population	studies,	there	are	expected	timelines	for	teeth	to	both	erupt	
and	emerge	during	human	growth	and	development,	either	from	a	perspective	of	chronological	
age,	or	from	the	viewpoint	of	cell	and	tissue	development.	Many	different	conditions	and	
phenomena	have	the	potential	to	cause	a	deviation	from	the	expected	timelines	in	tooth	
eruption,	but	in	spite	of	their	extensive	study,	the	nature	of	the	forces	behind	dental	eruption	is	
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still	a	controversial	topic31.	The	variety	of	conditions	that	may	result	in	delayed	tooth	eruption	
is	indeed	vast,	and	it	ranges	from	systemic	conditions	and	affecting	all	of	the	dentition	and	even	
other	organ	systems	as	well,	to	localized	elements	that	only	affect	one	dental	unit	at	a	time31.		
Conditions	that	affect	the	eruption	of	all	teeth	can	also	affect	their	development,	size,	shape	
structure	and	color	when	they	are	syndromic;	such	is	the	case	with	Dentinogenesis	Imperfecta,	
Amelogenesis	Imperfecta,	and	Dentinal	Dysplasia31.	Malnutrition,	Downs	Syndrome	and	
Hypopituitarism	can	also	result	in	teeth	having	shorter	roots	than	expected	when	they	erupt	
compared	to	the	general	population31.	Localized	elements	that	can	result	in	physical	
obstruction	of	dental	eruption	include	supernumerary	teeth,	tumors	or	either	odontogenic	or	
non-odontogenic	origin,	cysts,	scar	tissue	secondary	trauma	or	surgical	procedures,	and	gingival	
fibromatosis31.	The	current	understanding	of	tooth	eruption	is	surprisingly	poor,	as	is	our	
knowledge	of	many	of	the	conditions	in	which	this	process	is	impaired31.	Dental	ankylosis	is	a	
very	illustrative	example	of	the	gaps	in	our	current	knowledge	with	regard	to	tooth	eruption	
and	its	related	pathology.			
Dental	ankylosis	is	a	phenomenon	that	was	described	in	the	literature	as	early	as	1932	
when	Noyes	referred	to	primary	teeth	that	appeared	to	be	“sinking	into	the	tissues”	23.	
Normal	and	healthy	teeth	are	in	a	state	of	continual	eruption	and	any	stoppage	of	this	
movement	can	be	considered	abnormal7.	 In	ankylosis,	the	cementum	of	the	affected	tooth	
becomes	fused	with	alveolar	bone7.	A	tooth	may	become	ankylosed	along	any	part	of	its	
root8.	As	teeth	adjacent	to	one	that	is	ankylosed	retain	 their	eruption	potential	and	keep	
erupting	over	 time,	the	ankylosed	tooth	becomes	progressively	apical	to	the	plane	of	
occlusion,	giving	the	appearance	of	“sinking	into	bone”	30.	Not	only	can	ankylosis	lead	to	a	
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tooth	that	is	infra-occluded,	but	it	can	also	be	detrimental	to	the	development	of	the	
alveolar	process30.	Although	this	condition	was	observed	in	many	patients	in	the	early	
twentieth	century,	limitations	in	the	diagnostic	aides	and	laboratory	techniques	of	those	days	
narrowed	the	scope	and	depth	of	studies	that	could	be	carried	out	in	an	attempt	to	elucidate	
its	causes	and	pathological	process.	Early	research	on	dental	ankylosis	provided	better	
information	on	its	incidence	and	clinical	presentation,	while	theories	on	its	etiology	were	
more	speculative	in	nature.		
Dental	Ankylosis:	A	Diagnostic	Challenge	
	
One	of	the	complications	in	gathering	data	during	clinical	studies	of	dental	ankylosis	is	
that	the	condition	can	be	challenging	to	detect	and	diagnose	correctly	compared	to	other	
causes	of	delayed	tooth	eruption31.	The	methods	most	relied	upon	by	dental	professionals	to	
diagnose	this	condition	in	a	clinical	setting	are	percussion	and	mobility	tests	as	well	as	
radiographic	examination5.	Ankylosed	teeth	are	thought	to	lack	any	mobility	due	to	the	fusion	
of	their	root	surface	with	the	surrounding	bone,	and	to	produce	a	clear	and	high-pitched	
noise,	which	in	healthy	teeth	would	be	dampened	by	the	PDL6.	The	percussion,	mobility,	and	
radiographic	methods	however	provide	no	histological	assessment	of	the	relationship	
between	the	root	surface	of	a	tooth	and	its	surrounding	bone.	Andersson	et	al.	contrasted	
these	three	widely	used	clinical	methods	with	a	subsequent	histological	analysis	in	a	monkey	
animal	model	by	examining	incisors	that	were	extracted	and	replanted	experimentally4.	They	
found	that	in	order	for	a	tooth	to	consistently	present	abnormal	mobility	and	sound	on	
tapping,	ankylosis	must	affect	more	than	twenty	percent	of	its	root	surface4.	These	abnormal	
results	are	only	present	approximately	half	of	the	time	in	teeth	that	have	an	affected	root	
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surface	that	is	between	ten	and	twenty	percent	of	the	total,	and	teeth	with	an	affected	
surface	of	less	than	ten	percent	of	the	total	show	no	clinical	difference	with	unaffected	
teeth4.	Diagnosis	of	dental	ankylosis	based	on	radiological	evaluations	can	be	even	more	
problematic.	When	ankylosis	is	present	at	the	buccal	or	lingual	surfaces	of	the	dental	root,	it	
is	not	radiologically	evident;	it	can	only	be	detected	by	that	method	if	it	is	present	on	the	
proximal	surfaces	of	the	tooth,	giving	rise	to	many	false	negatives4.	Furthermore,	it	has	been	
observed	that	a	thin	layer	of	bone	on	the	root	surface	can	be	linked	to	the	surrounding	
alveolar	bone	by	thin	trabeculae	and	give	the	appearance	of	a	periodontal	ligament	in	a	
radiograph,	which	contributes	to	false	negatives	even	when	the	condition	affects	proximal	
root	surfaces4.		
In	2012,	Resonance	Frequency	Analysis	was	proposed	as	a	new	diagnostic	tool	for	
dental	ankylosis6.	This	technique	is	most	often	used	as	a	measure	of	stability	in	dental	
implants	by	measuring	the	implant	to	bone	interface	based	on	resonance	frequencies	during	
oscillations	exerted	into	the	implant	and	bone	contact	point6,21,32.	Although	initial	studies	
suggest	that	RFA	might	provide	greater	sensitivity	than	more	traditional	methods	in	the	
diagnosis	of	dental	ankylosis,	more	testing	will	have	to	take	place	before	it	is	implemented	
widely.	The	practicality	and	economic	feasibility	of	using	this	technique	and	the	equipment	it	
requires	in	a	private	orthodontic	office	is	not	yet	clear	throughout	the	literature.	For	a	
conclusive	diagnosis	of	dental	ankylosis,	histological	examination	of	a	specimen	removed	
from	the	oral	cavity	remains	the	diagnostic	gold	standard.	
Incidence	and	Clinical	Presentation	
	
Despite	the	diagnostic	challenge	that	dental	ankylosis	represents,	in	the	mid	1950’s,	
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reports	in	the	literature	described	the	growing	knowledge	regarding	the	epidemiological	
factors	of	this	condition	in	its	different	clinical	presentations.	The	primary	second	molar	
was	identified	early	on	as	the	dental	unit	that	was	affected	most	often	even	though	the	
condition	could	be	observed	in	both	permanent	and	deciduous	dentition8.	Work	by	
Biederman	in	1956	illustrated	that	dental	ankylosis	was	a	selective	condition	with	regard	to	
its	onset	during	dental	development	and	the	location	of	the	dental	units	it	affected8.	By	
comparing	119	patients	who	presented	with	two	ankylosed	deciduous	second	molars	each,	
he	statistically	determined	that	the	clinical	presentation	of	dental	ankylosis	followed	a	
discreet	pattern	that	was	not	random8.	Among	his	findings,	he	showed	that	the	condition	
occurred	in	the	teeth	of	the	mandible	more	than	twice	as	frequently	as	the	teeth	of	the	
maxillary	arch	and	that	more	than	ninety	percent	of	the	affected	teeth	were	either	first	or	
second	primary	molars8.	Biederman’s	work	also	laid	an	early	foundation	towards	
elucidating	the	pathophysiology	of	dental	ankylosis	through	his	observation	that	the	
condition	being	present	in	one	dental	unit	did	not	correlate	with	its	occluding	counterpart	
being	affected	as	well,	thus	undermining	the	early	theory	that	dental	ankylosis	was	caused	
by	traumatic	or	heavy	occlusal	forces8.	As	an	alternative	theory,	Biederman	postulated	that	
dental	ankylosis	was	probably	caused	by	“some	metabolic	disturbance	of	a	local	character”	
8.	In	a	later	study,	nearly	ten	years	afterward,	Biederman	went	to	greater	length	to	
contrast	dental	ankylosis	with	the	natural	dental	eruption	process	and	characterize	it	as	
pathology.	He	contrasted	ankylosed	teeth	with	impacted	teeth	by	pointing	out	how	the	
later	retain	their	eruption	potential	and	can	continue	to	progress	into	the	oral	cavity	and	
occlusal	plane	once	mechanical	obstructions	are	removed	from	their	eruption	path,	while	
	 6	
ankylosed	teeth	do	not	have	an	eruption	potential	any	longer	and	will	not	emerge	into	the	
oral	cavity	or	occlusal	plane	once	mechanical	obstacles	are	cleared	from	their	path7.	The	
body	of	literature	available	by	that	time	confirmed	the	earlier	observations	that	dental	
ankylosis	was	specific	with	respect	to	its	location	in	the	oral	cavity,	with	nearly	all	affected	
teeth	being	primary	or	permanent	molars	and	mandibular	teeth	being	represented	more	
than	twice	as	often	as	maxillary	teeth7.	Additionally,	this	phenomenon	also	appeared	to	be	
specific	with	respect	to	time	of	onset	since	deciduous	teeth	were	represented	over	
permanent	teeth	by	a	ratio	greater	than	ten	to	one7.		
Two	different	presentations	have	been	observed	in	the	roots	of	teeth	with	dental	
ankylosis4.	In	some	cases,	resorption	of	cementum	and	dentin	has	been	observed,	while	in	
others	there	is	direct	deposition	of	bone	on	top	of	cementum	in	the	root	of	the	ankylosed	
tooth4.	By	the	nineteen-eighties,	Andersson	et	al.	had	enough	sources	and	evidence	to	
report	that	ankylosis	was	also	observed	as	a	common	complication	of	avulsed	permanent	
teeth	that	were	replanted4,	while	Kurol	reported	that	a	familial	tendency	in	the	pattern	of	
ankylosis	of	primary	molars	could	be	demonstrated19.		
Although	the	epidemiology	and	clinical	presentation	of	dental	ankylosis	has	been	well	
documented	in	the	literature,	the	exact	pathologic	mechanism	that	gives	rise	to	this	condition	
remains	unclear.	Advances	in	elucidating	its	pathological	process	are	discussed	next.		
Etiology	of	Dental	Ankylosis:	What	is	Currently	Known	
	
Although	theories	have	been	offered	to	explain	the	biologic	process	that	 leads	to	
dental	ankylosis,	 its	mechanism	has	never	been	demonstrated.	4,7.	Dental	ankylosis,	being	
the	fusion	of	a	tooth’s	cementum	with	bone,	may	not	occur	as	long	as	the	periodontal	
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ligament	of	said	tooth	is	intact2.	Biederman	was	among	the	first	to	speculate	that	ankylosis	
could	be	caused	either	by	an	incompletely	developed	periodontal	ligament	or	by	its	partial	
local	ossification8.	He	further	hypothesized	that	a	disturbed	local	metabolism	would	cause	
an	alteration	of	the	periodontal	membrane	and	lead	to	the	fusion	of	the	surrounding	bone	
with	the	tooth’s	cementum	by	way	of	lysis	of	the	membrane8.	Biederman’s	work	also	
showed	that	dental	ankylosis	was	not	likely	to	have	a	systemic	cause,	since	the	dental	units	
were	not	all	affected	equally	nor	did	the	condition	present	itself	at	the	same	rate	
throughout	dental	development8.	During	the	middle	of	the	twentieth	century,	it	was	
hypothesized	that	traumatic	occlusal	forces	might	be	a	causative	factor	for	ankylosis;	
Biederman,	however,	observed	that	in	patients	who	displayed	multiple	ankylosed	teeth,	
these	were	most	of	the	time	not	in	occlusion	with	each	other8.	Furthermore,	although	
molars	are	subjected	to	greater	occlusal	forces,	and	they	also	suffer	from	ankylosis	at	a	
greater	rate	than	other	types	of	dental	units,	the	occlusal	forces	in	an	adult’s	permanent	
dentition	are	much	greater	than	the	ones	deciduous	teeth	experience	in	a	primary	or	
mixed	dentition	patient.	The	fact	that	dental	ankylosis	occurs	in	primary	molars	at	ten	
times	the	rate	of	permanent	molars	suggests	that	traumatic	occlusal	forces	are	not	a	
significant	etiologic	factor7.		
An	alternative	hypothesis	that	has	been	offered	is	that	a	congenital	or	genetic	gap	in	
the	periodontal	membrane	of	some	patients	not	only	may	lead	to	dental	ankylosis7,	but	
would	also	account	for	the	familial	tendency	in	its	development	reported	by	Kurol19.	Sharawy	
et	al.	(1968)	also	implicated	genetic	factors	in	addition	to	environmental	insults	when	
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describing	and	analyzing	dental	ankylosis	that	was	produced	experimentally	using	a	rat	
animal	model28.		
Biederman’s	theory	of	“arrhythmic	metabolism”	postulated	that	as	a	tooth	erupts,	
there	are	alternate	phases	of	local	resorption	and	deposition	of	bone	on	one	side	of	the	
periodontal	ligament	and	of	cementum	on	the	other	side,	which	allows	for	adjustment	of	
Sharpey	fibers	along	the	root	surface	while	the	periodontal	ligament	remains	intact7.	Under	
normal	circumstances,	the	periodontal	ligament	disappears	after	the	roots	of	a	deciduous	
tooth	are	resorbed,	but	if	the	PDL	disappears	or	is	not	continuous	any	longer	before	root	
resorption,	then	cementum	and	bone	can	come	into	contact,	leading	to	dental	ankylosis7.		
Animal	Studies	on	the	Etiology	of	Dental	Ankylosis.		
	
Andersson	et	al.	made	further	inroads	into	elucidating	the	pathophysiology	of	dental	
ankylosis	in	the	1980’s	when	they	created	the	condition	experimentally	through	dental	
extractions	and	re-plantations	in	a	monkey	animal	model4.	After	carrying	out	histological	
examinations,	they	further	subdivided	dental	ankylosis	into	two	distinct	categories:	the	
majority	in	which	ankylosis	had	been	preceded	by	resorption	of	both	cementum	and	dentine,	
and	no	cementum	was	found	at	the	ankylosed	site;	and	a	smaller	subset	in	which	apposition	
of	bone	on	the	cemental	surface	had	occurred	without	previous	resorption	of	the	
cementum4.	The	latter	type	was	found	to	be	more	common	along	the	apical	part	of	the	root	
surface4.	Rubin	et	al.	also	employed	a	monkey	animal	model	in	order	to	experimentally	cause	
dental	ankylosis	in	deciduous	teeth26.	In	their	study,	five	different	methods	were	used	in	an	
attempt	to	create	dental	ankylosis	in	four	separate	animal	subjects:	one	subject	had	its	
periodontal	ligament	surgically	exposed	and	injured	with	a	periodontal	curette	(mechanical	
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periodontal	trauma);	a	second	subject	had	one	tooth	subjected	to	chemical	trauma	(using	
phenol)	at	the	PDL	following	surgical	exposure,	while	a	second	tooth	was	denuded	of	its	PDL	
at	the	distal	root	using	a	dental	bur;	a	third	subject	received	a	stainless	steel	crown	that	
would	contact	the	opposing	tooth	prematurely;	and	the	final	subject	had	a	tooth	luxated	with	
forceps26.	Follow	up	histological	analysis	revealed	that	the	three	animals	that	underwent	
periodontal	trauma,	root	trauma,	and	hyperocclusion	showed	no	evidence	of	dental	
ankylosis;	wound	repair	resulted	in	new	bone	that	was	still	separated	from	the	root	
cementum	by	a	thin	periodontal	ligament26.	The	subject	that	had	its	tooth	luxated	was	the	
only	one	to	display	histologic	evidence	of	true	ankylosis,	making	the	case	against	occlusion	or	
damage	to	parts	of	the	PDL	as	possible	etiologic	factors	26.		
More	recently,	Fujiyama	et	al.	(2004)	were	able	to	experimentally	produce	dental	
ankylosis	in	the	rat	by	transecting	the	Inferior	Alveolar	Nerve	(IAN);	this	procedure	resulted	in	
dento-alveolar	ankylosis	and	a	decrease	in	width	of	periodontal	spaces14.		Malassez	
Epithelium	(ME)	is	imbedded	in	the	periodontal	ligament	predominantly	along	the	coronal	
root	surface;	after	denervation,	it	has	been	observed	that	its	distribution	decreases	within	
one	week	postsurgcially14.	This	reduction	in	Malassez	Epithelium	precedes	dental	ankylosis	
along	the	coronal	root	surface	by	a	margin	of	approximately	six	weeks14.	No	degenerative	
changes	were	reported	along	the	apical	periodontal	ligament	region,	which	is	densely	
innervated	by	the	IAN,	suggesting	that	it	is	not	the	denervation	that	directly	results	in	
ankylosis,	but	the	decrease	in	Malassez	Epithelium,	which	must	have	a	role	in	maintaining	the	
periodontal	space,	preventing	alveolar	bone	fragments	from	migrating	into	the	cementum	
surface14.	Fujiyama	et	al.	(2004)	put	forward	the	explanation	that	the	ME	and	cementoblasts	
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secrete	molecules	to	inhibit	osteogenesis	in	the	periodontal	space;	suggesting	that	the	ME	
plays	an	inhibitory	role	in	the	appearance	of	osteoclasts	and	odontoclasts	in	this	anatomical	
region14.	The	ME	has	also	been	implicated	in	the	formation	of	acellular	cementum	through	
epithelium	to	mesenchyme	interactions,	and	it	is	hypothesized	that	its	absence	results	in	
lesser	cementum	formation,	which	leads	to	root	resorption14.		In	cases	in	which	the	ME	
recovered	by	regeneration	after	the	surgical	denervation,	the	reduced	periodontal	spaces	
increased	in	width	once	again14.	The	ME,	however,	is	located	predominantly	on	the	coronal	
end	of	the	PDL,	which	means	that	other	mechanisms	that	are	less	well	understood	must	play	
a	role	in	maintaining	the	width	of	the	periodontal	space	towards	the	apical	end	of	the	root	
surface14.	These	reports	in	the	literature	make	the	case	for	a	multitude	of	possible	etiological	
processes	resulting	in	dental	ankylosis	and/or	replacement	resorption,	with	a	compromise	of	
the	inhibitory	effect	of	the	Malassez	Epithelium	playing	a	role	in	the	coronal	end	of	the	root	
surface,	while	other	unidentified	mechanisms	predominate	in	the	apical	end14.			
The	Possible	Role	of	RANKL	and	Bone	Morphogenetic	Proteins	(BMPs)	in	Dental	Ankylosis	
	
Earlier	in	this	review,	it	was	described	how	some	works	in	the	literature	argue	for	the	
secretion	by	cementum	and	the	Malassez	Epithelium	of	inhibiting	factors	that	prevent	dental	
ankylosis	and/or	replacement	resorption	along	the	dental	root	surface.	The	tissues	of	the	PDL	
also	contain	progenitor	cells	that	are	capable	of	forming	bone,	cementum	and	PDL	connective	
tissue	matrix,	as	well	as	endogenous	growth	factors	that	facilitate	tissue	homeostasis22.	Some	
of	those	endogenous	growth	factors	are	Bone	Morphogenetic	Proteins	(BMPs);	molecules	
that	facilitate	periodontal	bone	regeneration	but	have	also	been	implicated	in	causing	
ankylosis	and	root	resorption22.	BMPs	are	a	group	of	approximately	twenty	distinct	proteins	
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belonging	to	the	superfamily	of	transforming	growth	factor-β	(TGF-	β).	They	play	critical	parts	
in	cardiac,	neural,	and	cartilage	development	and	one	of	their	main	functions	is	to	induce	
pluripotent	cells	to	commit	to	the	osteoblastic	lineage	and	form	new	bone22.	Because	of	their	
ability	to	stimulate	intramembranous	bone	formation,	BMPs	are	of	interest	in	periodontal	bone	
regeneration16;	research	has	shown,	however,	that	their	use	could	result	in	tooth	ankylosis	and	
root	resorption15.		There	is	evidence	in	the	literature	that	BMPs	induce	apoptosis	in	
progenitor	cells22.	With	regard	to	the	progenitor	cells	of	the	PDL	specifically,	Muthukuru	et	al.	
have	demonstrated	that	their	cytotoxicity	when	exposed	to	BMP-2	is	ten	times	greater	
compared	to	osteoblasts22.	It	has	been	postulated	that	disruption	of	PDL	homeostasis	by	
BMP-induced	apoptosis	could	play	a	role	in	dental	ankylosis22.		Together	with	BMP-2,	other	
members	of	this	cytokine	family	such	as	BMP-4	and	BMP-6	have	been	reported	to	have	high	
osteoinductive	potential,	influencing	regeneration	and	healing	of	bone27,29,	bone	
formation18,33,	and	odontogenesis1,9.	The	precise	roles	that	these	cytokines	may	or	may	not	
play	during	Dental	Ankylosis	are	an	active	area	of	research	where	much	remains	to	be	
learned.		
The	Receptor	Activator	of	Nuclear	factor-Kappa	B,	also	known	as	RANK,	is	a	membrane	
bound	receptor	that	has	been	identified	in	many	tissues	of	the	human	body,	such	as	muscle,	
liver,	brain,	kidney,	lung,	and	trabecular	bone3.	RANK	is	activated	by	binding	to	RANK-ligand,	
also	known	as	RANKL	and	osteoclast	differentiation	factor,	resulting	in	osteoclastic	
differentiation	and	activation20.	Some	authors	have	proposed	that	altered	expression	of	
RANKL	may	be	related	to,	or	even	play	a	key	role	in	root	resorption	during	orthodontic	tooth	
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movement10.	Additionally,	mice	with	a	compromised	RANKL	gene	have	been	shown	to	have	
severe	osteopetrosis	and	defects	in	tooth	eruption	by	Kong	et	al.17	
Although	the	precise	etiology	of	dental	ankylosis	within	the	larger	spectrum	of	
eruption	disorders	remains	unclear,	the	involvement	of	BMPs	and	RANKL	in	the	homeostasis	
and	remodeling	of	bone	as	well	as	their	possible	link	to	dental	root	resorption	make	them	
ideal	subjects	to	study	in	order	to	confirm	or	rule	out	their	relevance	in	the	etiology	of	dental	
ankylosis.	
Primary	Failure	of	Eruption	and	its	Possible	Relation	to	Dental	Ankylosis	
	
Primary	Failure	of	Eruption	(PFE)	was	first	described	in	the	literature	by	Proffit	and	
Vig24	and	 its	subcategories	have	s ince	been	characterized	 in	the	 literature25.	These	
subcategories,	or	types,	are	defined	in	terms	of	timing	of	onset	and	presentation.	Type	I	
PFE	is	characterized	by	a	progressive	posterior	open	bite.	In	Type	1	PFE	all	teeth	distal	to	
the	most	mesial	infra-	occluded	tooth	are	affected	and	do	not	erupt	into	occlusion.	Type	II	
PFE,	on	the	other	hand,	displays	greater	eruption	as	compared	to	Type	1,	yet	it	 is	still	
inadequate	for	the	more	distal	teeth,	such	as	second	molars25.	
Clinical	signs	common	to	PFE	and	ankylosis	 include	supracrestal	position	of	the	
affected	teeth	and	involvement	of	the	first	permanent	molar25.	Although	teeth	with	PFE	
present	with	anomalies	 in	their	eruption	mechanism,	they	do	not	display	fusion	of	
cementum	to	bone	as	is	the	case	in	ankylosis25.	It			has	been	observed	that	in	ankylosis,	
the	affected	tooth	is	confined	to	only	1	dental	arch,	while	in	PFE	74%	of	the	patients	are	
affected	in	both	arches25.	Rhoads	et	al.	(2013)	have	also	shown	that	without	knowledge	of	
prior	trauma,	treatment	history	of	the	tooth,	damage	to	the	PDL,	or	genetic	mutations,	
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PFE	and	Ankylosis	might	be	 indistinguishable	clinically25.	 	
Rhoads	et	al.	described	PFE	as	mainly	affecting	posterior	teeth25.	Moreover,	the	
defect	in	eruption	caused	by	PFE	manifests	as	a	 lateral	open	bite	and	the	teeth	affected	
by	it	do	not	respond	to	orthodontic	treatment25.	Recent	studies	have	shown	that	some	
cases	of	eruption	failure	as	caused	by	a	genetic	mutation.	Specifically,	genetic	mutations	
in	one	gene,	PTH1R,	have	been	associated	with	PFE	and	10%-40%	of	cases	have	a	familial	
component25.	Those	genetic	mutations	 identified	 include	but	are	not	 limited	 to,	missense,	
substitution	and	 intron-skipping	mutations11-13.	Rhoads	et	al.identified	a	mutation	that	
revealed	PFE	 in	the	deciduous	dentition25.	Although	a	mutation	in	PTH1R	confirms	a	
diagnosis	of	PFE,	a	lack	of	it	is	not	definitive	in	ruling	out	this	diagnosis,	as	PFE	is	believed	
to	be	caused	by	more	than	one	gene	since	PFE	cases	were	identified	without	a	causative	
mutation	 in	PTH1R25.		 Recent	genotype:phenotype	studies	revealed	that	the	hallmark	
features	of	PFE	that	provide	a	definitive	diagnosis	 include:	1)	 involvement	of	the	first	
permanent	molar,	supracrestal	presentation	of	the	affected	teeth,	and	a	posterior	 lateral	
open	bite25.	Provided	that	other	alternative	causes	for	 it	are	ruled	out,	such	as	mechanical	
failure	of	eruption	or	skeletal	discrepancies,	these	diagnostic	criteria	serve	as	a	definitive	
clinical	rubric25.	Other	clinical	hallmarks	associated	with	a	mutation	 in	PTH1R,	are	
involvement	of	the	second	premolar	and	the	second	molar,	multiple	 adjacent	 teeth	
affected,	 supracrestal	presentation	of	 the	 infraoccluded	 teeth,	bilateral	presentation,	
involvement	of	teeth	 in	both	 the	maxilla	and	 the	mandible,	frequent	Class	 III	
malocclusion,	and	a	high	prevalence	of	concurrent	dental	anomalies25.	Definitive	diagnosis	
of	PFE	 is	currently	made	through	the	identification	of	a	mutation	 in	the	PTH1Rgene,	which	
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has	been	shown	to	be	largely	consistent	with	the	diagnosis	of	PFE	based	on	clinical	
parameters.	
Gaining	a	deeper	understanding	of	the	relationship	between	ankylosis	and	Primary	
Failure	of	Eruption	has	the	potential	to	 impact	the	treatment	decision	process	 in	
orthodontics.	Ankylosis	can	be	successfully	 treated	by	extraction	of	the	ankylosed	tooth	
and	subsequent	orthodontic	movement	of	all	other	teeth.	This	 is	 in	contrast	to	patients	
suffering	from	PFE,	which	have	more	limited	treatment	options	at	 their	disposal,	 including	
small	 segmental	osteotomies	and	prosthetic	 restorations	of	 the	occlusion25.	For	a	patient	
suffering	from	PFE,	orthodontic	treatment	with	a	continuous	archwire	results	 in	
exacerbation	of	the	lateral	open	bite	by	intrusion	of	the	adjacent	teeth	and,	frequently,	
ankylosis	of	the	affected	teeth	regardless	of	whether	or	not	the	most	affected	of	them	are	
extracted25.	Unlike	cases	of	ankylosis,	no	treatment	or	 limited	esthetic	treatment	is	often	
the	best	option	for	patients	suffering	from	PFE.	Cases	of	PFE	that	are	misdiagnosed	and	
treated	with	a	continuous	archwire	can	actually	 lead	to	an	inferior	occlusal	end	result,	
leaving	the	patient	in	worse	condition	compared	to	the	start	of	treatment.		Investigating	
the	clinical	and	molecular	differences	or	similarities	between	Dental	Ankylosis	and	PFE	will	
form	the	basis	of	future	genetic	tests	that	will	 improve	the	diagnosis	and	clinical	
management	of	 the	 two	conditions.	
Conclusion	
	
	 Dental	ankylosis	has	been	reported	in	the	scientific	literature	at	least	since	the	early	
twentieth	century.	The	clinical	presentation	and	epidemiology	of	this	phenomenon	were	
documented	and	characterized	early	on	in	spite	of	the	difficulties	in	diagnosing	this	
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pathology	and	contrasting	it	to	other	cases	of	delayed	tooth	eruption.	Such	diagnostic	
difficulties	persist	to	this	day	in	spite	of	advances	in	genetics,	radiology,	and	other	imaging	
techniques,	forcing	dental	professionals	to	rely	on	methods	that	present	limited	sensitivity	
and	a	high	degree	of	subjectivity.	New	approaches	to	diagnose	the	condition	are	being	
explored,	but	they	are	still	in	their	infancy	conceptually	and	technically.		
Advances	in	biochemistry	and	molecular	biology	have	led	to	the	elucidation	of	many	
physiological	pathways	with	regard	to	metabolism,	remodeling	and	repair	in	the	tissues	of	
the	alveolar	bone,	PDL	and	dental	root	surface.	Progress	in	these	areas	provides	us	with	
multiple	areas	to	study	as	we	examine	the	possible	factors	that	play	a	role	in	the	
pathological	process	leading	to	dental	ankylosis,	a	condition	whose	etiology	is	not	
completely	understood	to	this	day.	
By	comparing	dental	ankylosis	with	other	eruption	disorders	such	as	Primary	Failure	
of	Eruption	at	a	molecular	and	genetic	level,	it	will	be	possible	to	establish	whether	these	
conditions	are	completely	distinct	and	unrelated	or	part	of	a	wider	spectrum	of	aberrant	
physiology.		A	greater	understanding	of	their	differences	and	similitudes	as	well	as	the	exact	
processes	that	give	rise	to	them	will	lead	to	improved	diagnosis	in	terms	of	sensitivity	and	
accuracy,	resulting	in	better-informed	clinical	decisions	and	improved	outcomes	for	all	
dental	patients.		
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DENTAL	ANKYLOSIS:	CLINICAL	AND	MOLECULAR	CHARACTERIZATION	
Background	and	Introduction	
	
	 Tooth	eruption	is	the	developmental	process	behind	the	movement	of	a	dental	unit	
from	the	crypt	where	it	forms,	across	the	bone	of	the	jaws,	and	into	the	oral	cavity,	towards	
its	place	across	a	functional	occluding	counterpart		15.	It	is	without	a	doubt	a	complex	process,	
involving	many	tissues	and	cell	types	that	are	coordinated	with	precision	and	specificity	in	
time	and	space	15.	The	downside	of	this	very	complexity,	however,	is	that	it	presents	many	
elements	and	mechanisms	that	have	the	potential	to	go	awry.	Based	on	population	studies,	
there	are	expected	timelines	for	teeth	to	both	erupt	and	emerge	during	human	growth	and	
development,	either	from	a	perspective	of	chronological	age,	or	from	the	viewpoint	of	cell	
and	tissue	development.	Many	different	conditions	and	phenomena	have	the	potential	to	
cause	a	deviation	from	the	expected	timelines	in	tooth	eruption,	but	in	spite	of	their	
extensive	study,	the	nature	of	the	forces	behind	dental	eruption	is	still	a	controversial	topic	
15.	The	current	understanding	of	tooth	eruption	is	surprisingly	poor,	as	is	our	knowledge	of	
many	of	the	conditions	in	which	this	process	is	impaired	15.	Dental	ankylosis	is	a	very	
illustrative	example	of	the	gaps	in	our	current	knowledge	with	regard	to	tooth	eruption	and	
its	related	pathology.	Biederman	compared	119	patients	who	presented	with	two	ankylosed	
deciduous	second	molars	each,	and	he	statistically	determined	that	the	clinical	
presentation	of	dental	ankylosis	followed	a	discreet	pattern	that	was	not	random	4.	Among	
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his	findings,	he	showed	that	the	condition	occurred	in	the	teeth	of	the	mandible	more	than	
twice	as	frequently	as	the	teeth	of	the	maxillary	arch	and	that	more	than	ninety	percent	of	
the	affected	teeth	were	either	first	or	second	primary	molars	4.	In	the	1980s,	Andersson	et	
al.	had	enough	sources	and	evidence	to	report	that	ankylosis	was	also	observed	as	a	
common	complication	of	avulsed	permanent	teeth	that	were	replanted	3,	while	Kurol	
reported	that	a	familial	tendency	in	the	pattern	of	ankylosis	of	primary	molars	could	be	
demonstrated	9.		
Dental	ankylosis	has	been	reported	in	the	scientific	literature	at	least	since	the	early	
twentieth	century.	The	clinical	presentation	and	epidemiology	of	this	phenomenon	were	
documented	and	characterized	early	on	in	spite	of	the	difficulties	in	diagnosing	this	
pathology	and	contrasting	it	to	other	cases	of	delayed	tooth	eruption.	Such	diagnostic	
difficulties	persist	to	this	day	in	spite	of	advances	in	genetics,	radiology,	and	other	imaging	
techniques,	forcing	dental	professionals	to	rely	on	methods	that	present	limited	sensitivity	
and	a	high	degree	of	subjectivity.	New	approaches	to	diagnose	the	condition	are	being	
explored,	but	they	are	still	in	their	infancy	conceptually	and	technically.	
Advances	in	biochemistry	and	molecular	biology	have	led	to	the	elucidation	of	many	
physiological	pathways	with	regard	to	metabolism,	remodeling	and	repair	in	the	tissues	of	
the	alveolar	bone,	PDL	and	dental	root	surface.	Progress	in	these	areas	provides	us	with	
multiple	areas	to	study	as	we	examine	the	possible	factors	that	play	a	role	in	the	
pathological	process	leading	to	dental	ankylosis,	a	condition	whose	etiology	is	not	
completely	understood	to	this	day.	
One	of	the	complications	in	gathering	data	during	clinical	studies	of	dental	ankylosis	
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is	that	the	condition	can	be	challenging	to	detect	and	diagnose	correctly	compared	to	other	
causes	of	delayed	tooth	eruption	15.	For	a	conclusive	diagnosis	of	dental	ankylosis,	
histological	examination	of	a	specimen	removed	from	the	oral	cavity	remains	the	diagnostic	
gold	standard.	
By	comparing	dental	ankylosis	with	other	eruption	disorders	such	as	Primary	Failure	
of	Eruption	at	a	molecular	and	genetic	level,	it	will	be	possible	to	establish	whether	these	
conditions	are	completely	distinct	and	unrelated	or	part	of	a	wider	spectrum	of	aberrant	
physiology.		A	greater	understanding	of	their	differences	and	similitudes	as	well	as	the	exact	
processes	that	give	rise	to	them	will	lead	to	improved	diagnosis	in	terms	of	sensitivity	and	
accuracy,	resulting	in	better-informed	clinical	decisions	and	improved	outcomes	for	all	
dental	patients.		
Materials	and	Methods	
	
Patient	Recruitment	
	
This	study	was	approved	by	the	the	Institutional	Review	Board	at	the	University	of	North	
Carolina	at	Chapel	Hill.	Two	patients	were	recruited	to	participate	in	this	study:	one	from	the	
Graduate	Orthodontic	Clinic	at	the	University	of	North	Carolina	School	of	Dentistry,	and	one	
from	a	private	Oral	and	Maxillofacial	Surgery	practice	in	Charlotte,	North	Carolina.	Assent	and	
consent	forms	were	obtained	from	the	patients	and	their	legal	guardians	and	the	medical	and	
dental	histories	of	both	patients	were	carefully	recorded.	Patient	A	was	selected	to	participate	
in	the	study	due	to	a	dental	history	presenting	an	infraoccluded	mandibular	first	molar	which	
did	not	respond	to	orthodontic	therapy.	The	affected	tooth	was	the	only	one	to	display	this	
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presentation,	and	the	patient’s	family	history	was	not	indicative	of	any	recurring	eruption	
disorders	across	generations,	putatively	ruling	out	the	possibility	of	a	familial	case	of	Primary	
Failure	of	Eruption	(PFE)	and	suggesting	Patient	A	suffered	from	dental	ankylosis.		
		
Figure	1	a:	Patient	A	Intraocclusal	Photographs	
Figure	1	b:	Patient	A	Panoramic	Radiograph	
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Patient	B	on	the	other	hand,	did	present	with	a	family	history	of	dental	eruption	issues.	
The	patient’s	dental	presentation	showed	a	supracrestal	but	infraoccluded	first	molar,	as	well	
as	posterior	teeth	being	affected	distal	to	that	tooth.	Both	Patient	B’s	dental	and	family	history	
suggested	the	patient	suffers	from	a	familial	case	of	PFE.	Not	only	did	Patient	B’s	mother	and	
sibling	were	affected	by	a	lateral	open	bite	like	Patient	B	was,	but	they	all	shared	a	presentation	
in	which	the	same	side	of	the	dental	arches	was	consistently	affected	across	generations.	This	
inherited	specificity	in	the	location	of	PFE	affected	teeth	has	not	been	reported	in	a	familial	
case	in	the	literature	before.	The	presence	of	a	contralateral	unaffected	tooth	allowed	for	
comparison	to	a	control	during	the	study	as	well.	Based	on	this	dental	presentation	and	family	
history,	Patient	B	was	recruited	to	serve	as	a	putative	PFE	patient	in	this	study.		
Figure	2	a:	Patient	B	Intraocclusal	Photographs	
Figure	2	b:	Patient	B’s	sibling,	Intraocclusal	Photographs	
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Figure	2	c:	Patient	B’s	mother,	Intraocclusal	Photographs	
	
Figure	2	d:	Patient	B	panoramic	radiograph	
	
Sample	Procurement	
	
Both	patients	were	scheduled	to	undergo	dental	extractions	which	were	treatment	
planned	prior	to	their	involvement	in	this	study	regardless	of	the	subjects’	participation.	Patient	
A	had	extractions	of	the	maxillary	first	premolars,	mandibular	right	second	premolar,	and	
mandibular	left	first	molar	(affected	tooth)	as	part	of	orthodontic	treatment.	His	mandibular	
right	second	premolar	(#29	in	the	Universal	System	of	Dental	Nomenclature)	and	his	
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mandibular	left	first	molar	(#19)	were	collected	to	serve	as	the	control	and	affected	tooth	for	
Patient	A,	respectively.	Patient	B	had	all	third	molars	extracted	in	preparation	for	corticotomies	
to	address	a	lateral	open	bite.	The	maxillary	left,	mandibular	left,	and	maxillary	right	third	
molars	were	collected	from	Patient	B	for	use	in	the	study;	teeth	#16	and	#17	served	as	affected	
or	experimental,	while	#1	served	as	the	unaffected	control	(tooth	#32	was	too	damaged	during	
extraction	to	be	useful	in	the	study).	Collected	specimens	were	placed	in	Minimal	Essential	
Medium	(MEM)	and	immediately	used	to	start	a	primary	cell	culture	following	the	protocol	of	
Scanlon	et	al.	14.	After	plating	of	the	primary	cell	culture,	the	extracted	teeth	were	transferred	
to	RNAlater	in	order	to	preserve	the	RNA	in	the	PDL	tissue.	
Primary	Cell	Cultures	
	
Tissues	from	the	Periodontal	Ligament	(PDL)	of	the	extracted	teeth	specimens	were	
used	to	start	primary	cell	culture	lines	following	the	protocol	of	Scanlon	et	al.	14.	Sections	of	PDL	
tissue	were	dissected	from	the	root	surfaces	using	a	sterile	scalpel	blade	and	pinned	down	
against	the	bottom	of	a	100	mm	petri	dish	using	a	glass	microscope	cover	slip	that	was	slightly	
smeared	with	sterile	petroleum	jelly	in	one	of	its	sides	for	retention	purposes.	12	mL	of	
Minimum	Essential	Media	containing	10%	Fetal	Bovine	Serum,	1%	antimycotic	and	1%	
antibacterial	agents	was	added	to	each	plate	and	the	plates	were	incubated	at	37°	Celsius	and	
5%	CO2.	When	the	cells	reached	approximately	75%	to	80%	confluence,	they	were	separated	
from	their	plates	and	re-plated	for	a	new	passage.		
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Figure	3	a:	Patient	A,	tooth	#29	cell	culture	
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Figure	3	b:	Patient	A,	tooth	#19	cell	culture	
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Figure	3	c:	Patient	B,	tooth	#1	cell	culture	
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Figure	3	d:	Patient	B,	tooth	#16	cell	culture	
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Figure	3	e:	Patient	B,	tooth	#17	cell	culture	
	
RNA	Extraction		
	
	 Each	cell	line	was	harvested	after	3	passages	in	order	to	extract	RNA	to	be	used	
in	genetic	expression	studies.	RNA	was	extracted	from	the	cell	cultures	using	TRIzol®	reagent	
and	following	the	manufacturer’s	instructions	(ThermoFisher	Scientific,	Waltham,	MA):	Growth	
media	was	removed	from	culture	dish	and	8mL	of	TRIzol®	were	added	to	the	100mm	petri	
dishes.	Cells	in	the	culture	were	lysed	by	pipetting	up	and	down	several	times	and	were	then	
incubated	at	room	temperature	for	5	min.	A	volume	of	1.6mL	of	chloroform	was	then	added	to	
each	sample	and	the	tubes	were	shaken	vigorously	for	15	sec	prior	to	incubation	at	room	
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temperature	for	3	min.	Next,	the	samples	were	centrifuged	at	12,000g	for	15	min	at	4°C.	The	
aqueous	phase	of	the	sample	was	removed	by	pipetting	and	placed	in	a	new	tube.	4mL	of	100%	
isopropanol	was	added	to	the	aqueous	phase	of	each	sample,	incubated	for	10	min	at	room	
temperature	and	centrifuged	at	12,000g	for	10	min	at	4°C.		
After	the	supernatant	was	discarded,	the	RNA	pellet	was	washed	with	8	mL	of	75%	ethanol,	
vortexed,	and	centrifuged	at	7500g	for	5	min	at	4°C.	The	wash	was	discarded	and	the	pellets	
were	air	dried	for	10	minutes	before	being	reuspended	in	50	μL	of	RNase-free	water.	The	RNA	
samples	were	incubated	at	60°C	for	10	min	and	stored	at	-70°C	afterwards.		 	
RT-PCR	
	
A	Reverse	Transcriptase-Polymerase	Chain	Reaction	(RT-PCR)	was	performed	on	the	
extracted	RNA	samples	using	Superscript®	III	Reverse	Transcriptase	(Thermofisher	Scientific,	
Waltham,	MA).	For	each	reaction	using	RNA,	a	negative	control	using	an	equal	volume	of	water	
instead	of	reverse	transcriptase	was	run	was	well.		For	each	reaction,	the	following	reagents	
and	conditions	were	employed:	1	μL	of	Random	Primers	(ThermoFisher	Scientific,	Waltham,	
MA),	2	μL	of	10	mM	dNTP	(ThermoFisher	Scientific)	and	13	μL	of	H2O	at	65°	C	for	5	min	before	
addition	of	8	μL	5X	Superscript®	III	buffer		(ThermoFisher	Scientific,	Waltham,	MA),	2	μL	0.1	M	
DTT	(ThermoFisher	Scientific,	Waltham,	MA),	1	μL	RNasin	(Promega),	and	1	μL	H2O.		Samples	
were	then	incubated	at	room	temperature	for	5	min,	followed	by	60	min	at	50°C.	The	reactions	
were	inactivated	for	15	min	at	70°C	and	80	μL	of	H2O	was	added	to	each	final	cDNA	sample.		
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Real	Time	PCR		
	
The	resulting	cDNA	samples	were	amplified	by	quantitative	real	time	polymerase	chain	
reaction	(qPCR)	using	primers	specific	for	the	housekeeping	gene	Glycderaldehyde-3-phosphate	
dehydrogenase	(GAPDH),	as	well	as	the	candidate	genes	PTH1R,	RANKL,	BMP2,	BMP4,	and	
BMP6.	A	StepOnePlus™	Real-Time	PCR	System	(Applied	Biosystems,	Foster	City,	CA)	was	
employed	for	the	qPCR	under	the	following	conditions:	10	min	at	95°C		activation/premelt,	then	
45	cycles	of	10	sec	at	95°C,	10	sec	at	60°C	and	20	sec	at	72°C.	The	Melt	Curve	stage	consisted	of	
15	sec	at	95°C,	then	1	min	at	60°C,	and	15	sec	at	95°C.	Primer	sequences	are	displayed	in	Table	
1:	
Table	1:	Primer	sequences	used	in	qPCR	
Gene	 Forward	Primer	(5’-3’)	 Reverse	Primer					(5’-3’)	 Annealing	(°C)	 Reference	
BMP-2	 atggattcgtggtggaagtg	 gtggagttcagatgatcagc	 58	 	7	
BMP-4	 agcagccaaactatgggcta	 tggttgagttgaggtggtca	 60	 	20	
BMP-6	 cgtgaaggcaatgctcacct	 cctgtggcgtggtatgctgt	 64	 	6	
RANKL	 ctatttcagagcgcagatggat	 tatgagaacttgggattttgatgc	 61	 	16	
PTH1R	 ggggcttcacagtcttcg	 tggccagggtagctctga	 60	
Roche	
Probefinder	
NM_000316.2	
GAPDH	 acacccactcctccaccttt	 tgacaaagtggtcgttgagg	 60	 	
	
	
Mutational	Analysis		
	
Saliva	samples	were	collected	from	both	patients	in	order	to	extract	DNA	(Oragene,	DNA	
Genotek,	Toronto,	Canada)	for	downstream	mutational	analysis.		Our	working	hypothesis,	that	
Patient	A	has	ankylosis	and	Patient	B	has	PFE,	required	that	we	identify	or	rule	out	mutations	in	
the	PTH1R	gene.		DNA	samples	were	amplified	by	PCR	using	primers	specific	for	all	coding	exons	
of	the	PTH1R	gene	under	the	following	conditions:	under	the	following	conditions:	2min	95°C	
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activation/premelt,	followed	by	35	cycles	of	30	sec	at	95°C	melt,	1	min	at	60°C	anneal,	and	3	
min	of	72°C	extension.	PCR	Products	were	then	purified	using	ExoSaplt	(USB,	Cleveland	OH),	
and	sequenced	at	the	University	of	North	Carolina	at	Chapel	Hill	Genome	Analysis	Core	facility.	
Primer	sequences	are	listed	in	Table	2.	
Table	2:	PTH1R	primer	sequences	used	during	mutational	analysis	
PTH1R	Primer	
	
Sequence	(5'	to	3')	
	
PTHR1050MutF	 gaatgaccttgtggacagca	
PTHR1050MutR	 gaagcctcctaggtccctgt	
PTHR1543AND463Mut
F	 gccctgtccggactacatt	
PTHR1543AND463Mut
R	 cagggagagcatcagggtaa	
PTHR1ex3F	 ctctgcaccccctacca	
PTHR1ex3R	 cccaaacgaggcttcag	
PTHR1ex4F	 aaatcccaccttccctct	
PTHR1ex4R	 ccttcacctggctctgtat	
PTHR1ex5F	 cacctggcaagcacttta	
PTHR1ex5R	 aagagccaagaagcatgag	
PTHR1ex6F	 ttcatccttctgggtcacta	
PTHR1ex6R	 aggttgctggaggagtca	
PTHR1ex8F	 tgactcctccagcaacct	
PTHR1ex8R	 cgccgtaggtagggaca	
PTHR1ex10F	 ccactctacctcttcactttg	
PTHR1ex10R	 ggaatagggtcaggatcac	
PTHR1ex11F	 aagctgttagggcaccac	
PTHR1ex11R	 cttgaggctggactgagaa	
PTHR1ex12F	 ttctcagtccagcctcaag	
PTHR1ex12R	 gctctgtcactgcatctctg	
PTHR1ex14F	 tattagcacttagccaggaca	
PTHR1ex14R	 agggtggaagaatggagaa	
Results		
	
Sequencing	analysis	of	patient	A	revealed	no	obvious	mutations.	A	representative	
example	of	a	chromatogram	is	provided	in	Figure	4a.	The	mutational	analysis	for	patient	B	
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revealed	a	possible	frameshift	mutation	due	to	insertion	at	gene	PTH1R,	and	further	deep	
sequencing	will	be	carried	out	to	corroborate	this	finding	(Figure	4b).		
	
	
Figure	4	a:		Patient	A,	PTH1R	Exon	8F	chromatogram	
	
	
	
Figure	4	b:	Patient	B,	PTH1R	Exon	3	chromatogram	
	
	Differences	in	expression	were	observed	between	some	candidate	genes	across	the	five	
samples.	Amplification	plots	with	positive	results	for	the	housekeeping	gene	GAPDH	(Figures	
4c-g)	were	observed	for	all	samples	tested.	The	candidate	genes	RANKL	and	BMP-2	(Figures	8a-
e	and	5a-e,	respectively)	were	found	not	to	be	genetically	expressed	across	any	of	the	samples.	
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Candidate	gene	BMP-4,	however,	was	found	to	be	expressed	in	the	control	samples	for	both	
Patient	A	and	Patient	B	as	well	as	in	the	ankylosed	tooth	of	Patient	A;	this	candidate	gene	was	
not	found	to	be	expressed	in	the	teeth	affected	by	PFE	of	Patient	B	(Figures	6a-e).	Additionally,	
candidate	gene	BMP-6	was	found	to	be	expressed	in	one	of	the	teeth	affected	by	PFE	on	
Patient	B,	#16,	while	it	was	not	found	to	be	expressed	in	any	of	the	other	samples	(Figure	7a-e).	
Candidate	gene	PTH1R,	was	only	found	to	be	expressed	in	tooth	#19	of	Patient	A	(Figures	9a-e).		
	
GAPDH	
	
Figure	4	c:	Patient	A,	#29	(control),	GAPDH	qPCR	analysis.Ct=15.68	
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Figure	4	d:	Patient	A,	#19	(ankylosed),	GAPDH	qPCR	analysis.Ct=15.8	
	
	
	
	
	
	
Figure	4	e:	Patient	B,	#1	(control),	GAPDH	qPCR	analysis.	 Ct=15.54	
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Figure	4	f:	Patient	B,	#16	(PFE),	GAPDH	qPCR	analysis.	Ct=13.74	
	
	
	
	
	
	
	
	
Figure	4	g:	Patient	B,	#17	(PFE),	GAPDH	qPCR	analysis.	Ct=15.39	
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BMP-2	
	
	
Figure	5	a:	Patient	A,	#29	(control),	BMP-2	qPCR	analysis.		
	
	
	
	
	
Figure	5	b:	Patient	A,	#19	(ankylosed),	BMP-2	qPCR	analysis.		
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Figure	5	c:	Patient	B,	#1	(control),	BMP-2	qPCR	analysis.	
	
	
	
	
	
	
	
Figure	5	d:	Patient	B,	#16	(PFE),	BMP-2	qPCR	analysis.		
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Figure	5	e:	Patient	B,	#17	(PFE),	BMP-2	qPCR	analysis.	
	
	
BMP-4	
	
	
	
	
Figure	6	a:	Patient	A,	#29	(control),	BMP-4	qPCR	analysis.	Ct=15.66	
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Figure	6	b:	Patient	A,	#19	(ankylosed),	BMP-4	qPCR	analysis.	Ct=18.78	
	
	
	
	
	
	
Figure	6	c:	Patient	B,	#1	(control),	BMP-4	qPCR	analysis.	Ct=15.14	
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Figure	6	d:	Patient	B,	#16	(PFE),	BMP-4	qPCR	analysis.	
	
	
	
	
	
	
	
Figure	6	e:	Patient	B,	#17	(PFE),	BMP-4	qPCR	analysis.	
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BMP-6	
	
	
	
	
Figure	7	a:	Patient	A,	#29	(control),	BMP-6	qPCR	analysis.	
	
	
	
Figure	7	b:	Patient	A,	#19	(ankylosed),	BMP-6	qPCR	analysis.	
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Figure	7	c:	Patient	B,	#1	(control),	BMP-6	qPCR	analysis.	
	
	
	
	
	
	
	
Figure	7	d:	Patient	B,	#16	(PFE),	BMP-6	qPCR	analysis.	Ct=14.17	
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Figure	7	e:	Patient	B,	#17	(PFE),	BMP-6	qPCR	analysis.	
	
	
	
RANKL	
	
	
Figure	8	a:	Patient	A,	#29	(control),	RANKL	qPCR	analysis.	
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Figure	8	b:	Patient	A,	#19	(ankylosed),	RANKL	qPCR	analysis.	
	
	
	
	
	
Figure	8	c:	Patient	B,	#1	(control),	RANKL	qPCR	analysis.	
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Figure	8	d:	Patient	B,	#16	(PFE),	RANKL	qPCR	analysis.	
	
	
	
	
	
	
Figure	8	e:	Patient	B,	#17	(PFE),	RANKL	qPCR	analysis.	
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PTH1R	
	
	
	
Figure	9	a:	Patient	A,	#29	(control),	PTH1R	qPCR	analysis.		
	
	
	
	
Figure	9	b:	Patient	A,	#19	(ankylosed),	PTH1R	qPCR	analysis.	Ct=	14.54	
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Figure	9	c:	Patient	B,	#1	(control),	PTH1R	qPCR	analysis.		
	
	
	
	
Figure	9	d:	Patient	B,	#16	(PFE),	PTH1R	qPCR	analysis.	
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Figure	9	e:	Patient	B,	#17	(PFE),	PTH1R	qPCR	analysis.		
The	results	of	the	qPCR	analysis	are	summarized	by	Table	3:	
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Table	3:	qPCR	results	by	Ct	value	
	 GAPDH	
(Ct)	
BMP-2	
(Ct)	
BMP-4	
(Ct)	
BMP-6	
(Ct)	
RANKL	
(Ct)	
PTH1R		
(Ct)	
Patient	A,	
#29	
15.68	 Negative	 15.66	 Negative	 Negative	 Negative	
Patient	A,	
#19	
15.8	 Negative	 18.78	 Negative	 Negative	 14.54	
Patient	B,	
#1	
15.54	 Negative	 15.14	 Negative	 Negative	 Negative	
Patient	B,	
#16	
13.74	 Negative	 Negative	 14.17	 Negative	 Negative	
Patient	B,	
#17	
15.39	 Negative	 Negative	 Negative	 Negative	 Negative	
	
In	order	to	compare	the	candidate	genes’	relative	expression	level	compared	to	that	of	
the	housekeeping	gene	GAPDH,	ΔCt	values	were	calculated	for	those	samples	that	tested	
positive	by	subtracting	the	Ct	value	of	GAPDH	from	the	Ct	value	of	the	positive	assay.		The	
resulting	values	are	shown	on	Table	4:	
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Table	4:	ΔCt	values	of	positive	qPCR	results	(ΔCt	=	Cttest	–	CtGAPDH)	
Sample	and	gene	
tested	
Positive	Ct	Value	 GAPDH	value	 ΔCt	value	
Patient	A,	#29,	
BMP-4	 15.66	 15.68	 -0.02	
Patient	A,	#19,	
BMP-4	 18.78	 15.8	 2.98	
Patient	A,	#19,	
PTH1R	 14.54	 15.8	 1.26	
Patient	B,	#1,			BMP-
4	 15.14	 15.54	 -0.4	
Patient	B,	#16,	
BMP-6	 14.17	 13.74	 0.43	
	
	 Candidate	gene	BMP-4	was	found	to	be	expressed	at	a	higher	rate	with	respect	to	
GAPDH	across	all	positive	samples	with	exception	of	Patient	A’s	ankylosed	tooth	(#19).	
Candidate	gene	BMP-6	was	expressed	at	a	higher	rate	compared	to	GAPDH	for	Patient	B’s	
affected	upper	PFE	tooth,	#16.	Candidate	gene	PTH1R	was	expressed	at	a	higher	rate	than	the	
housekeeping	gene	in	the	ankylosed	tooth	of	Patient	A	only	at	a	higher	rate	than	the	
housekeeping	gene.		
Discussion.		
	
	
Bone	Morphogenetic	Proteins	are	key	players	in	many	processes	of	bone	metabolism	
such	as	formation,	repair,	regeneration,	healing	and	callus	formation.	Although	the	
physiological	process	of	bone	turnover	involves	at	least	200	different	elements	that	influence	
the	cells	of	bone	metabolism,	such	as	osteoblasts	and	osteoclasts,	and	interact	with	one	
another	as	well	7,	BMPs	have	been	described	as	the	most	important	factors,	together	with	
Platelet	Derived	Growth	Factor	(PTGF)	and	Transforming	Growth	Factor	Beta	(TGF-β),	in	the	
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process	of	bone	healing	7.	Not	only	are	BMPs	important	for	bone	physiology,	but	they	have	also	
been	documented	to	regulate	apoptosis	in	many	other	types	of	tissues	5,12.	In	this	study,	the	
BMPs	studied	showed	differences	in	expression	between	each	other	and	across	the	different	
samples	provided.	Amplification	plots	with	positive	results	for	the	housekeeping	gene	GAPDH	
(Figures	4a-e)	attest	to	the	metabolic	health	of	the	primary	cell	cultures	and	viability	of	the	RNA	
sample	they	yielded	after	their	harvest	and	processing.	RANKL	was	not	found	to	be	expressed	in	
any	of	the	samples	tested	and	there	are	several	possible	explanations	to	this	finding.	Liu	et	al.	
(2005)	demonstrated	that	the	expression	of	RANKL	significantly	peaks	at	postnatal	days	9-11	in	
a	rat	animal	model	10.	Differentiation	of	progenitor	cells	into	osteoclasts	and	bone	resorption	
are	both	promoted	by	RANKL	and	the	expression	of	this	factor	could	be	regulated	in	a	time	
dependent	manner	to	coincide	with	active	eruption	of	a	dental	unit	through	bone	10.		
Furthermore,	expression	of	RANKL	in	order	to	achieve	a	burst	of	osteoclast	activity	has	also	
found	to	be	site	specific.	It	is	known	that	RANKL	is	expressed	in	both	the	dental	follicle	21	and	
alveolar	bone	18,	yet	in	knockout	mice	that	lack	RANKL,	rescue	with	a	transgene	in	B	and	T	
lymphocytes	does	not	restore	tooth	eruption	and	only	leads	to	bone	resorption	in	long	bones,	
while	alveolar	bone	does	not	show	an	increase	in	this	metabolic	process	2.	If	the	source	of	
RANKL	that	leads	to	tooth	eruption	and	resorption	in	alveolar	bone	is	the	dental	follicle	as	has	
been	theorized	in	the	literature	10,	then	the	samples	analyzed	in	this	study	would	not	be	
expected	to	show	expression	of	RANKL.	All	of	the	samples	in	this	study	came	from	teeth	that	
had	already	emerged	into	the	oral	cavity	and	they	did	not	present	a	dental	follicle	proper	any	
longer,	as	it	had	long	differentiated	into	PDL.	The	age	of	both	patients	at	the	time	of	the	study	
would	also	suggest	that	RANKL	was	not	going	through	an	expression	peak	either.		
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	 BMP-2	was	found	not	to	be	expressed	across	any	of	the	samples	tested.		We	speculate	
that	this	result	is	due	to	the	fact	that	no	active	bone	formation	was	being	induced.	BMP-2	is	
osteoinductive	and	it	has	been	shown	to	induce	osteoblast	differentiation	in	a	variety	of	cell	
types	11	,	whereas	RANKL	stimulates	progenitor	cells	to	differentiate	into	osteoclasts,	leading	to	
bone	resorption	10.	BMP-2	has	been	shown	to	down-regulate	RANKL	in	vitro	and	it	has	been	
proposed	to	promote	growth	of	alveolar	bone	around	a	dental	unit	10.	Just	like	RANKL,	
expression	of	BMP-2	has	been	shown	to	go	through	a	temporal	peak	in	a	rat	animal	model,	in	
this	case	around	day	9	post-natally	in	the	dental	follicle	17,19.	The	developmental	stage	of	the	
teeth	in	this	study	and	level	of	differentiation	of	the	dental	follicle	concur	with	the	finding	that	
BMP-2	was	not	expressed	in	any	of	the	samples	tested.		
	 BMP-6	was	only	found	to	be	expressed	in	one	of	the	PFE	affected	teeth	of	Patient	B	
(#16).		Literature	on	the	expression	of	BMP-6	across	different	bones	of	the	human	body,	such	as	
the	cranial	flat	bones,	corpus	mandibulae,	diaphysis	radii,	distal	epiphysis	radii,	alaossis	ilii,	
diaphysis	femoris	and	distal	epiphysis	femoris	has	shown	similar	results.	Kochanowska	et	al.,	in	
a	study	of	all	of	the	bones	mentioned	above,	found	the	BMP-6	gene	not	to	be	expressed	in	any	
of	the	samples	studied	during	baseline	7.	It	appears	that	the	role	of	BMP-6	is	more	closely	
associated	with	bone	repair,	leading	to	its	expression	only	as	a	response	to	a	localized	insult	7.	
We	theorize	that	the	positive	result	in	our	study	was	due	to	a	localized	insult	to	alveolar	bone	
of	tooth	#16	in	Patient	B	since	she	reported	a	previous	corticotomy	attempt	in	that	quadrant	
and	it	is	not	a	result	of	different	expression	levels	between	ankylosed	teeth	and	teeth	affected	
by	PFE	or	between	affected	teeth	and	controls,	as	this	result	was	not	observed	in	tooth	#17	of	
patient	B,	which	is	affected	by	PFE	as	well.		
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	 PTH1R	was	another	candidate	gene	with	observed	differences	in	expression	across	the	
samples	tested.	In	bone,	PTH1R	is	a	receptor	expressed	on	the	cell	surface.	Activation	of	the	
receptor	by	binding	to	its	substrate,	PTH,	leads	to	expression	of	RANKL,	which	leads	to	an	
increase	in	the	differentiation	of	osteoclasts	and	bone	resorption.	Bone	resorption	and	
remodeling	have	been	observed	to	accompany	root	replacement	resorption	in	teeth	that	suffer	
from	dental	ankylosis		3.		In	a	patient	that	suffers	from	a	tooth	with	dental	ankylosis,	such	as	
Patient	A,	PTH1R	would	be	expected	to	be	expressed	in	order	to	see	the	changes	in	vertical	
height	of	the	alveolar	bone	and	replacement	resorption	that	often	coincides	with	dental	
ankylosis.	PTH1R	was	found	to	be	expressed	in	the	putatively	ankylosed	tooth,	we	therefore	
speculate	that	this	tooth	does	not	suffer	from	PFE.	
	 BMP-4		was	found	to	be	expressed	in	all	teeth	with	the	exception	of	the	2	teeth	affected	
by	PFE	on	patient	B.		This	candidate	gene	is	important	for	bone	and	cartilage	metabolism	as	a	
member	of	the	Bone	Morphogenetic	Protein	family	7.	Specifically	to	the	craniofacial	complex,	
tooth	formation	relies	on	BMP4	expression	8and	mutations	in	this	gene	are	associated	with	
orofacial	cleft	and	microphthalmia		1.	It	is	an	especially	compelling	result	that	only	the	teeth	
affected	by	PFE	failed	to	display	any	expression	of	BMP-4,	since	not	all	of	the	genes	responsible	
for	PFE	have	been	identified	so	far.	Only	10	to	40%	of	PFE	cases	have	been	shown	to	be	familial,	
with	a	mutation	present	on	gene	PTH1R	and	not	all	causative	mutations	for	this	condition	have	
been	identified	13.	In	light	of	the	observed	expression	pattern	of	BMP-4	for	the	patients	in	this	
study,	we	propose	that	BMP-4	may	be	a	downstream	effector	in	a	pathway	affected	by	PTH1R	
mutations.	An	Ingenuity	Pathway	analysis	would	help	elucidate	this	and	should	be	done	in	
future	studies	that	also	look	at	a	RNA-SeQ	analysis	of	ankylosis	versus	PFE	affected	teeth.		
	 56	
These	and	other	future	studies	will	provide	immeasurable	insights	into	the	understanding	and	
future	translational	strategies	to	manage	PFE,	ankylosis	and	other	eruption	disorders.	
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